← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 31, 2016Last known activity
Feb 3, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03352232Reponsible party - principal investigatorEarly Phase 1Feb 3, 2018
- NCT03352232Overall official - principal investigatorEarly Phase 1Feb 3, 2018
- NCT03352232Lead sponsorEarly Phase 1Feb 3, 2018
- NCT03304444Reponsible party - principal investigatorPhase 3Aug 31, 2016
- NCT03304444Lead sponsorPhase 3Aug 31, 2016
Details
- Last known activity
- Feb 3, 2018